Antenatal Steroids at 35 Weeks: Benefit Assessment and Decision-Making
Betamethasone (2×12 mg IM 24h apart) or dexamethasone (4×6 mg IM 12h apart) accelerate fetal lung surfactant production. Benefit is gestational-age dependent:
| Gestational Age | RDS Reduction | NNT |
|---|---|---|
| 24–28 wk | ~50% | 2–3 |
| 29–33 wk | ~40% | 3–4 |
| 34–36 wk | ~30% | 6–10 |
| ≥37 wk | Minimal | — |
At 35 Weeks Specifically
- Lungs are near maturity; baseline RDS risk ~2–5%.
- Steroids further reduce RDS to ~1–3% (absolute risk reduction 1–3%).
- Also ↓ IVH, NEC, need for surfactant/mechanical ventilation.
- Single course is safe; no long-term neurodevelopmental harm in RCTs.
Decision Framework
- If delivery is imminent/planned <37 wk: Give steroids (ACOG/SMFM strong recommendation).
- If expectant management likely >7 days: Single rescue course may be considered if initial course >14 days prior (controversial; discuss with MFM).
- Maternal factors: Diabetes (transient hyperglycemia — monitor), chorioamnionitis (contraindicated — deliver instead), hypertension (no contraindication).
Shared decision-making: Review absolute benefit (small at 35 wk), minimal risks, and patient values. Document discussion.
Pregnancy & Health - Related Articles
- Pregnancy Timeline: When Is the First Prenatal Visit?
- Bleeding During Pregnancy: Why It's Not a Period and What It Could Mean
- Negative Pregnancy Test? Possible Reasons & What To Do
- Light Pink Discharge in Early Pregnancy: Implantation Bleeding vs. Other Causes
- Areola Changes in Pregnancy: Darkening, Enlargement & Other Causes
- Pregnancy Warning Signs: Abdominal Pain, Nausea, Headache, and Cervical Concerns
- Understanding Chemical Pregnancies: Positive Test, Negative Result
